OUTPATIENT LOW-DOSE COMPUTED-TOMOGRAPHY METRIZAMIDE MYELOGRAPHY AND EVALUATION OF LUMBAR-DISK DISEASE

被引：1

作者：

DUBLIN, AB

REID, MH

机构：

[1] UNIV CALIF DAVIS, SACRAMENTO MED CTR,MED CTR,DEPT RADIOL, DIV DIAGNOST RADIOL, NEURORADIOL SECT, SACRAMENTO, CA 95817 USA

[2] UNIV CALIF DAVIS, SACRAMENTO MED CTR,MED CTR,DEPT RADIOL, DIV DIAGNOST RADIOL, SACRAMENTO, CA 95817 USA

来源：

CT-JOURNAL OF COMPUTED TOMOGRAPHY | 1984年 / 8卷 / 02期

关键词：

D O I：

10.1016/0149-936X(84)90094-8

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Outpatient low-dose computed tomography metrizamide myelography (CTMM) for the evaluation of lumbar disc disease is described in 55 patients. Ten individuals (group 1) were studied using 3.5 ml of 150 mg I/ml (525 mg I total) of metrizamide. Forty-five additional patients (group 2) were examined with 5 ml of 110 mg I/ml (550 mg I total) concentration of metrizamide. Group 2 experienced less post-procedure headache (6.6%) and nausea (2.2%) than did group 1 (30 and 10%, respectively). Group 2 demonstrated a lowered rate of headache (P < 0.01) and showed a trend to less nausea (P < 0.09) than a recently published study describing full-dose lumbar myelography. CTMM in group 2 produced more uniform mixing of metrizamide than in group 1. Low-dose CTMM increased accuracy and reduced morbidity, patient cost and inconvenience as compared with routine full-dose lumbar myelography.

引用

页码：113 / 117

页数：5